Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Aug 7;21(29):8739-52.
doi: 10.3748/wjg.v21.i29.8739.

Inflammatory pouch disease: The spectrum of pouchitis

Affiliations
Review

Inflammatory pouch disease: The spectrum of pouchitis

Petros Zezos et al. World J Gastroenterol. .

Abstract

Restorative proctocolectomy with ileal-pouch anal anastomosis (IPAA) is the operation of choice for medically refractory ulcerative colitis (UC), for UC with dysplasia, and for familial adenomatous polyposis (FAP). IPAA can be a treatment option for selected patients with Crohn's colitis without perianal and/or small bowel disease. The term "pouchitis" refers to nonspecific inflammation of the pouch and is a common complication in patients with IPAA; it occurs more often in UC patients than in FAP patients. This suggests that the pathogenetic background of UC may contribute significantly to the development of pouchitis. The symptoms of pouchitis are many, and can include increased bowel frequency, urgency, tenesmus, incontinence, nocturnal seepage, rectal bleeding, abdominal cramps, and pelvic discomfort. The diagnosis of pouchitis is based on the presence of symptoms together with endoscopic and histological evidence of inflammation of the pouch. However, "pouchitis" is a general term representing a wide spectrum of diseases and conditions, which can emerge in the pouch. Based on the etiology we can sub-divide pouchitis into 2 groups: idiopathic and secondary. In idiopathic pouchitis the etiology and pathogenesis are still unclear, while in secondary pouchitis there is an association with a specific causative or pathogenetic factor. Secondary pouchitis can occur in up to 30% of cases and can be classified as infectious, ischemic, non-steroidal anti-inflammatory drugs-induced, collagenous, autoimmune-associated, or Crohn's disease. Sometimes, cuffitis or irritable pouch syndrome can be misdiagnosed as pouchitis. Furthermore, idiopathic pouchitis itself can be sub-classified into types based on the clinical pattern, presentation, and responsiveness to antibiotic treatment. Treatment differs among the various forms of pouchitis. Therefore, it is important to establish the correct diagnosis in order to select the appropriate treatment and further management. In this editorial, we present the spectrum of pouchitis and the specific features related to the diagnosis and treatment of the various forms.

Keywords: Idiopathic pouchitis; Pouchitis; Secondary pouchitis; Ulcerative colitis, Crohn’s disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Idiopathic pouchitis pathogenesis.
Figure 3
Figure 3
Normal pouch mucosa (A), mucosal granular pattern (edema) with disappearance of the mucosal vascular pattern (B).
Figure 4
Figure 4
Active pouchitis (A, B). The mucosal vascular pattern has been lost and the mucosa is characterized by diffuse redness, severe edema with erosions and ulcers.
Figure 2
Figure 2
The J-pouch anatomy (adapted and modified from Cima et al[40]).
Figure 5
Figure 5
Crohn’s ileo-pouchitis. Stenosis of the pouch outlet (A, B), normal appearing mucosa of the pouch (C), stenosis of the pouch inlet (D), stenosis of the afferent limb at 25 cm (E), linear deep ulcerations in the ileum (F), proximal stenosis of the ileum at 65 cm (G) and ulcers more proximally (H).
Figure 6
Figure 6
Pouchitis diagnostic algorithm (adapted and modified from Shen[15]). C. difficile: Clostridium difficile.
Figure 7
Figure 7
Pouchitis treatment algorithm (adapted and modified from Shen et al[15]). C. difficile: Clostridium difficile.

References

    1. Melton GB, Fazio VW, Kiran RP, He J, Lavery IC, Shen B, Achkar JP, Church JM, Remzi FH. Long-term outcomes with ileal pouch-anal anastomosis and Crohn’s disease: pouch retention and implications of delayed diagnosis. Ann Surg. 2008;248:608–616. - PubMed
    1. Fazio VW, Ziv Y, Church JM, Oakley JR, Lavery IC, Milsom JW, Schroeder TK. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg. 1995;222:120–127. - PMC - PubMed
    1. Ferrante M, Declerck S, De Hertogh G, Van Assche G, Geboes K, Rutgeerts P, Penninckx F, Vermeire S, D’Hoore A. Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Inflamm Bowel Dis. 2008;14:20–28. - PubMed
    1. Shen B, Fazio VW, Remzi FH, Delaney CP, Bennett AE, Achkar JP, Brzezinski A, Khandwala F, Liu W, Bambrick ML, et al. Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomoses. Am J Gastroenterol. 2005;100:93–101. - PubMed
    1. Seril DN, Yao Q, Shen B. The association between autoimmunity and pouchitis. Inflamm Bowel Dis. 2014;20:378–388. - PubMed